CCHFV vaccine development, current challenges, limitations, and future directions
- PMID: 37753088
- PMCID: PMC10518622
- DOI: 10.3389/fimmu.2023.1238882
CCHFV vaccine development, current challenges, limitations, and future directions
Abstract
Crimean-Congo hemorrhagic fever (CCHF) is the most prevalent tick-borne viral disease affecting humans. The disease is life-threatening in many regions of the developing world, including Africa, Asia, the Middle East, and Southern Europe. In line with the rapidly increasing disease prevalence, various vaccine strategies are under development. Despite a large number of potential vaccine candidates, there are no approved vaccines as of yet. This paper presents a detailed comparative analysis of current efforts to develop vaccines against CCHFV, limitations associated with current efforts, and future research directions.
Keywords: Crimean-Congo hemorrhagic fever virus; DNA-based vaccines; mRNA-based vaccines; vaccines; viral vectored vaccines; virus-like particle (VLP).
Copyright © 2023 Ahata and Akçapınar.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
